Asensus Surgical (ASXC) delivered earnings and revenue surprises of 16.67% and -32.39%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Asensus Surgical (ASXC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
The medical equipment industry has been growing at a healthy clip this year, with rising demand for elective surgeries that had been on hold during the worst of the COVID-19 pandemic last year. So, two...
Abbott's (ABT) revised 2021 forecast continues to reflect strong, double-digit EPS growth despite lower COVID-19 testing demand.
Myriad Genetics' (MYGN) new divesture will provide the company with growth capital for future investments.
Mercy's outreach laboratory services are set to get integrated into Quest Diagnostics' (DGX) full-service laboratory in Lenexa, KS.
Investors are optimistic about STERIS (STE) owing to strong segmental performance and huge growth potential in healthcare and pharmaceutical industries.
With great sadness, Cocrystal Pharma, Inc. (Nasdaq: COCP), ("Cocrystal" or the "Company") announces that Gary Wilcox, Ph.D., Chairman, CEO and co-founder, suddenly passed away Wednesday, May 26 at the...
, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for SOS, GME, EDU, ASXC, and NBRV.
, /PRNewswire/ -- Autism spectrum disorder (ASD) represents a group of neurodevelopmental disorders or disabilities; it is a heritable and a polygenic disorder. Autism spectrum disorder is lifelong and...